Tilray Brands announces it has agreed to acquire HelloMD Corporation, a digital health platform, as part of efforts to strengthen its global medical cannabis business and improve patient access in Canada. The company says the acquisition is intended to expand access for Canadian patients and to bolster its digital healthcare capabilities. Tilray positions the deal as a way to support a more integrated medical cannabis framework by combining its medical cannabis operations with HelloMD’s technology. The Financial Post describes the announcement as targeting a vertically integrated structure in Canada, while Seeking Alpha also reports the acquisition of the HelloMD digital health platform.
While the available excerpts confirm the transaction and its general goals—greater patient access and added digital health functionality—the specific financial terms of the acquisition, timeline details, and regulatory or closing conditions are not included in the provided text. Tilray’s announcement is dated June 29, 2026, and is presented as a strategic move within its broader medical cannabis and healthcare strategy.
